Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Upper Extremity Disorders”

11,187 trials

Showing 20 of 11,187 results

Testing effectiveness (Phase 2)UnknownNCT05178836
What this trial is testing

A Phase II Study to Evaluate the Efficacy and Safety of F520 Combined With F007 in Patients With RR DLBCL

Who this might be right for
RR DLBCL; PD-1; CD20
Shandong New Time Pharmaceutical Co., LTD 62
Post-approval studies (Phase 4)Study completedNCT03406000
What this trial is testing

Phase 4 Study to Evaluate Treatment Optimization With Once-daily Insulin Glargine 300 U/mL

Who this might be right for
Type I Diabetes Mellitus
Sanofi 170
Not applicableStudy completedNCT03420807
What this trial is testing

Retinal Metabolic Imaging of Alzheimer Patient

Who this might be right for
Alzheimer Disease
Optina Diagnostics Inc. 49
Not applicableStudy completedNCT06077136
What this trial is testing

Whole Body Vibration in Rehabilitation of Spastic Cerebral Palsy

Who this might be right for
Cerebral Palsy
University of Hail 56
Testing effectiveness (Phase 2)Study completedNCT02768207
What this trial is testing

Detect V-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF) V600 Mutation on Cell-Free Deoxyribonucleic Acid (cfDNA) From Plasma in Participants With Advanced Melanoma

Who this might be right for
Metastatic Melanoma
Hoffmann-La Roche 40
Testing effectiveness (Phase 2)Looking for participantsNCT06971211
What this trial is testing

Radiotherapy Combined With Fluzopanib and Abiraterone Acetate Tablets (II) Treatment for mCRPC

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Jianbin Bi 40
Early research (Phase 1)Looking for participantsNCT07229911
What this trial is testing

TAK-781 in Healthy Volunteers and in Participants With Non-Cirrhotic Primary Sclerosing Cholangitis (PSC)

Who this might be right for
Healthy VolunteersPrimary Sclerosing Cholangitis
Takeda 134
Early research (Phase 1)Looking for participantsNCT05877300
What this trial is testing

Safety and Feasibility Study of the CELLSPAN Esophageal Implant (CEI) in Patients Requiring Short Segment Esophageal Replacement

Who this might be right for
Esophageal Diseases
Harvard Apparatus Regenerative Technology, Inc. 10
Not applicableStudy completedNCT06100107
What this trial is testing

Mirror Therapy in Complex Regional Pain Syndrome Type I

Who this might be right for
Complex Regional Pain Syndrome Type I
University Hospital, Motol 27
Not applicableStudy completedNCT04778436
What this trial is testing

Macula Evolution in Patients With AMD Taking Oral Food Supplementation

Who this might be right for
Age Related Macular Degeneration
Laboratoires Thea 10
Large-scale testing (Phase 3)Active Not RecruitingNCT06514807
What this trial is testing

Evaluate the Efficacy and Safety of Ropeginterferon Alfa-2b in Essential Thrombocythaemia Patients

Who this might be right for
Essential Thrombocythaemia
AOP Orphan Pharmaceuticals AG 117
Testing effectiveness (Phase 2)Study completedNCT00535392
What this trial is testing

Open-label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy

Who this might be right for
Epilepsy
UCB Pharma 33
Testing effectiveness (Phase 2)Study completedNCT00563836
What this trial is testing

Phase II Study of the Trifunctional Antibody Catumaxomab Administered Intra- and Postoperatively in Patients With Ovarian Cancer

Who this might be right for
Ovarian CancerEpithelial Ovarian Cancer
Neovii Biotech 41
Post-approval studies (Phase 4)Study completedNCT05134571
What this trial is testing

China Post-marketing Surveillance (PMS) Study of Aldurazyme®

Who this might be right for
Mucopolysaccharidosis I
Genzyme, a Sanofi Company 12
Large-scale testing (Phase 3)UnknownNCT02690636
What this trial is testing

Conventional Versus Hypofractionated Radiotherapy in Node Positive Breast Cancer

Who this might be right for
Breast Cancer
Ain Shams University 500
Large-scale testing (Phase 3)Study completedNCT00689936
What this trial is testing

Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 1,623
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07832292
What this trial is testing

JNJ-101556143 in Participants With Metastatic Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Janssen Research & Development, LLC 100
Large-scale testing (Phase 3)UnknownNCT04083911
What this trial is testing

Study of DAC Combined With HAAG Regimen in Newly Diagnosed AML Patients Older Than 60

Who this might be right for
Acute Myeloid LeukemiaInduction Chemotherapy
The First Affiliated Hospital of Soochow University 50
Large-scale testing (Phase 3)Study completedNCT00765700
What this trial is testing

Ketoprofen 10% Cream for Treatment of Pain Associated With Mild to Moderate Acute Soft Tissue Injury

Who this might be right for
SprainStrainAcute Soft Tissue Injury
Imprimis Pharmaceuticals, Inc. 364
Not applicableStudy completedNCT05170100
What this trial is testing

Evaluating a Digital Intervention for Overactive Bladder

Who this might be right for
Overactive Bladder
National University of Ireland, Galway, Ireland 29
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation